Msl Chemicals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.85 Cr
as on 24-10-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 4.00 Cr
as on 24-10-2024
- Revenue -17.50%
(FY 2023)
- Profit 67.85%
(FY 2023)
- Ebitda 47.15%
(FY 2023)
- Net Worth 59.53%
(FY 2023)
- Total Assets 161.84%
(FY 2023)
About Msl Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 1.85 Cr.
The company currently has active open charges totaling ₹12.00 Cr. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Madamadakala and Narendar Chimmula serve as directors at the Company.
- CIN/LLPIN
U24232TG2019PTC132421
- Company No.
132421
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2019
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Msl Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Madamadakala  | Director | 30-Apr-2019 | Current |
| Narendar Chimmula | Director | 30-Apr-2019 | Current |
Financial Performance of Msl Chemicals.
Msl Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.5% decrease. The company also saw a substantial improvement in profitability, with a 67.85% increase in profit. The company's net worth Soared by an impressive increase of 59.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Msl Chemicals?
In 2023, Msl Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Newgenics Labs Private LimitedActive 5 years 4 monthsRavinder Madamadakala and Narendar Chimmula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Mar 2023 | ₹12.00 Cr | Open |
The South Indian Bank Limited Creation Date: 10 Jun 2020 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Msl Chemicals?
Unlock and access historical data on people associated with Msl Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Msl Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Msl Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
